COGT logo

Cogent Biosciences (COGT) Current Liabilities

Annual Current Liabilities

$55.71 M
+$17.54 M+45.96%

December 31, 2024


Summary


Performance

COGT Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCOGTbalance sheetmetrics:

Quarterly Current Liabilities

$55.71 M
+$2.66 M+5.02%

December 31, 2024


Summary


Performance

COGT Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCOGTbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

COGT Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+46.0%0.0%
3 y3 years+226.2%0.0%
5 y5 years+320.5%+573.7%

COGT Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+226.2%at high+226.2%
5 y5-yearat high+325.5%at high+575.9%
alltimeall timeat high+537.6%at high+575.9%

Cogent Biosciences Current Liabilities History

DateAnnualQuarterly
Dec 2024
$55.71 M(+46.0%)
$55.71 M(+5.0%)
Sep 2024
-
$53.05 M(+32.6%)
Jun 2024
-
$40.00 M(+9.0%)
Mar 2024
-
$36.69 M(-3.9%)
Dec 2023
$38.17 M(+42.2%)
$38.17 M(+9.9%)
Sep 2023
-
$34.72 M(+34.8%)
Jun 2023
-
$25.76 M(+22.0%)
Mar 2023
-
$21.12 M(-21.3%)
Dec 2022
$26.85 M(+57.2%)
$26.85 M(+14.0%)
Sep 2022
-
$23.55 M(-14.8%)
Jun 2022
-
$27.66 M(+54.7%)
Mar 2022
-
$17.88 M(+4.7%)
Dec 2021
$17.08 M
$17.08 M(+2.2%)
Sep 2021
-
$16.71 M(+22.1%)
DateAnnualQuarterly
Jun 2021
-
$13.68 M(+66.0%)
Mar 2021
-
$8.24 M(-37.1%)
Dec 2020
$13.09 M(-1.2%)
$13.09 M(-34.9%)
Sep 2020
-
$20.12 M(+143.3%)
Jun 2020
-
$8.27 M(-10.6%)
Mar 2020
-
$9.25 M(-30.2%)
Dec 2019
$13.25 M(-46.9%)
$13.25 M(-45.8%)
Sep 2019
-
$24.43 M(+0.5%)
Jun 2019
-
$24.31 M(-2.6%)
Dec 2018
$24.95 M(+122.9%)
$24.95 M(-5.5%)
Sep 2018
-
$26.38 M(+6.3%)
Jun 2018
-
$24.81 M(+8.1%)
Mar 2018
-
$22.96 M(+105.2%)
Dec 2017
$11.19 M(+28.1%)
$11.19 M
Dec 2016
$8.74 M
-

FAQ

  • What is Cogent Biosciences annual total current liabilities?
  • What is the all time high annual current liabilities for Cogent Biosciences?
  • What is Cogent Biosciences annual current liabilities year-on-year change?
  • What is Cogent Biosciences quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Cogent Biosciences?
  • What is Cogent Biosciences quarterly current liabilities year-on-year change?

What is Cogent Biosciences annual total current liabilities?

The current annual current liabilities of COGT is $55.71 M

What is the all time high annual current liabilities for Cogent Biosciences?

Cogent Biosciences all-time high annual total current liabilities is $55.71 M

What is Cogent Biosciences annual current liabilities year-on-year change?

Over the past year, COGT annual total current liabilities has changed by +$17.54 M (+45.96%)

What is Cogent Biosciences quarterly total current liabilities?

The current quarterly current liabilities of COGT is $55.71 M

What is the all time high quarterly current liabilities for Cogent Biosciences?

Cogent Biosciences all-time high quarterly total current liabilities is $55.71 M

What is Cogent Biosciences quarterly current liabilities year-on-year change?

Over the past year, COGT quarterly total current liabilities has changed by $0.00 (0.00%)